Legend Biotech (LEGN) Intangibles (2019 - 2025)
Legend Biotech's (LEGN) quarterly Intangibles came in at $2.1 million in Q2 2025, down 22.91% YoY from $2.8 million in Q2 2024, and up 2.64% on a QoQ basis from $2.1 million in Q1 2025.
Legend Biotech (LEGN) Intangibles (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Intangibles data on file, last reported at $2.1 million in Q2 2025.
- Quarterly Intangibles fell 22.91% year-over-year to $2.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.1 million (down 22.91% YoY) and the FY2024 annual result came in at $2.2 million, down 46.81% from the prior year.
- Intangibles improved to $2.1 million in Q2 2025, from $2.1 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $6.4 million in Q4 2021 to a low of $4081.0 in Q1 2021.
- A 5-year average of $3.3 million and a median of $3.0 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2021 — Intangibles soared 521205.18% — and 2023, when it sank 49.32%.
- Tracing LEGN's Intangibles over 5 years: stood at $6.4 million in 2021, then sank by 46.75% to $3.4 million in 2022, then advanced by 19.13% to $4.1 million in 2023, then plunged by 46.81% to $2.2 million in 2024, then retreated by 1.06% to $2.1 million in 2025.
- The last three Intangibles figures came in at $2.1 million (Q2 2025), $2.1 million (Q1 2025), and $2.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Mar 31, 2022 | 4.52 Mn |
| Dec 31, 2021 | 6.40 Mn |
| Sep 30, 2021 | 5.43 Mn |
| Jun 30, 2021 | 4.68 Mn |
| Mar 31, 2021 | 4,081.00 |
| Dec 31, 2020 | 3.19 Mn |
| Sep 30, 2020 | 1,042.00 |
| Jun 30, 2020 | 978.00 |
| Dec 31, 2019 | 598,000.00 |